Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
25.03.24
/
50%
€16.50
Target price
25.03.25
€23.06
Performance (%)
-4.67%
End price
26.03.25
€15.73
Summary
This prediction ended on 26.03.25 with a price of €15.73. With a performance of -4.67%, the BUY prediction by JPMorgan_Chase___Co_ finished with a loss. JPMorgan_Chase___Co_ has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 1.320% | 1.320% | 31.185% |
| iShares Core DAX® | 2.850% | 3.312% | 26.690% |
| iShares Nasdaq 100 | 1.612% | 5.652% | 17.265% |
| iShares Nikkei 225® | 6.401% | 11.958% | 14.877% |
| iShares S&P 500 | 1.346% | 4.130% | 10.995% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
-4.20%
16:19
16:19
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.17
29.09.25
29.09.25
€28.15
29.09.26
29.09.26
1.65%
16:19
16:19
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
24.07.25
24.07.25
€28.88
24.07.26
24.07.26
-7.65%
16:19
16:19